Showing results (51-60 of 132) with videos related to
Sort By:
Pageof 14
Cancer Letters|February 5, 2000
Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in ratsH Li, P M Kramer, R A Lubet, et al.Cancer Research|July 23, 1999
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic processB S Reddy, T Kawamori, R A Lubet, et al.International Journal of Molecular Medicine|March 17, 2000
Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesisB S Reddy, Y Hirose, R A Lubet, et al.Anticancer Research|August 23, 2000
Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agentsS M D'Ambrosio, R Gibson-D'Ambrosio, G E Milo, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1994
Surrogate endpoint biomarkers for phase II cancer chemoprevention trialsG J Kelloff, C W Boone, J A Crowell, et al.Cancer Research|April 1, 1994
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trialsG J Kelloff, C W Boone, V E Steele, et al.International Journal of Cancer|July 3, 1997
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer modelR A Lubet, V E Steele, I Eto, et al.Carcinogenesis|March 9, 1999
Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt fociY Zheng, P M Kramer, R A Lubet, et al.Carcinogenesis|December 1, 1994
Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley ratsR A Lubet, V E Steele, T L Casebolt, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Chemopreventive drug development: perspectives and progressG J Kelloff, C W Boone, J A Crowell, et al.Pageof 14